Vivos Therapeutics (VVOS) Shares Issued (2020 - 2026)

Vivos Therapeutics (VVOS) has 6 years of Shares Issued data on file, last reported at $4.6 million in Q1 2026.

• Quarterly Shares Issued changed N/A year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.7 million (changed N/A YoY) and the FY2025 annual result came in at $866000.0, down 88.89% from the prior year.
• Shares Issued climbed to $4.6 million in Q1 2026 per VVOS's latest filing, from -$833000.0 in the prior quarter.
• Across five years, Shares Issued topped out at $8.0 million in Q1 2023 and bottomed at -$4.0 million in Q4 2023.
• The 4-year median for Shares Issued is $3.5 million (2024), against an average of $2.0 million.
• The widest annual swing landed in 2024, when Shares Issued jumped 187.5%; it then tumbled 123.8% in 2025.
• Tracing VVOS's Shares Issued over 4 years: stood at -$4.0 million in 2023, then jumped by 187.5% to $3.5 million in 2024, then plunged by 123.8% to -$833000.0 in 2025, then soared by 656.9% to $4.6 million in 2026.
• Per Business Quant, the three latest VVOS Shares Issued figures stand at $4.6 million (Q1 2026), -$833000.0 (Q4 2025), and $2.4 million (Q3 2025).

Peer Comparison